Robert F. Furchgott

Robert F. Furchgott was an American pharmacologist and Nobel laureate whose groundbreaking research fundamentally altered the understanding of blood vessel function. His most celebrated achievement was the discovery of endothelium-derived relaxing factor (EDRF), later identified as nitric oxide, a crucial signaling molecule in the cardiovascular system. This work, which demonstrated that the inner lining of blood vessels actively regulates vascular tone, earned him a share of the Nobel Prize in Physiology or Medicine in 1998 alongside Louis J. Ignarro and Ferid Murad. Furchgott's career spanned decades at prestigious institutions including Washington University in St. Louis and the SUNY Downstate Medical Center, where his meticulous experimental approach yielded profound insights into receptor theory and vascular physiology.

Early life and education

Robert Francis Furchgott was born in Charleston, South Carolina, and developed an early interest in science. He pursued his undergraduate studies in chemistry at the University of North Carolina at Chapel Hill, earning his degree in 1937. He then moved to the Midwest to undertake graduate work, receiving his Ph.D. in biochemistry from Northwestern University in 1940 under the mentorship of prominent figures in the field. His doctoral research focused on aspects of enzymology, laying a foundational knowledge base for his future investigations. Following his graduation, he began his postdoctoral training at Cornell University Medical College in New York City, an experience that steered his career toward the emerging discipline of pharmacology.

Research and career

Furchgott's independent research career began at Washington University in St. Louis School of Medicine, where he investigated the mechanisms of drug-receptor interactions. His early work made significant contributions to the understanding of adrenergic receptors, particularly those responsive to epinephrine and norepinephrine. In 1956, he moved to the SUNY Downstate Medical Center in Brooklyn, where he served as chairman of the Department of Pharmacology for many years. Throughout the 1960s and 1970s, his laboratory was renowned for its rigorous studies on vascular smooth muscle and the effects of various vasodilator and vasoconstrictor agents, using isolated tissue preparations like the rabbit aorta. This period of systematic inquiry set the stage for his paradigm-shifting discovery in the 1980s.

Discovery of endothelium-derived relaxing factor (EDRF)

The pivotal moment in Furchgott's career came from an accidental observation in 1978 while studying the effects of acetylcholine on isolated strips of rabbit aorta. He noted that the compound caused relaxation only if the inner lining, the endothelium, was intact; if removed, acetylcholine caused contraction. He presented this finding at a 1980 conference, proposing the existence of a labile humoral factor released by the endothelium, which he termed EDRF. This hypothesis challenged the prevailing view of the endothelium as a passive barrier. In subsequent years, through collaborative work with other pharmacologists, compelling evidence indicated that EDRF was identical to nitric oxide, a simple gas previously considered merely an environmental pollutant. This discovery unveiled nitric oxide as a vital biological messenger regulating blood pressure, neurotransmission, and immune response.

Awards and honors

Furchgott's contributions were recognized with numerous prestigious awards. In 1991, he received the Gairdner Foundation International Award. He was a co-recipient of the Albert Lasker Award for Basic Medical Research in 1996, often considered a precursor to the Nobel Prize. The pinnacle of recognition came in 1998 when he was awarded the Nobel Prize in Physiology or Medicine, jointly with Louis J. Ignarro and Ferid Murad, "for their discoveries concerning nitric oxide as a signaling molecule in the cardiovascular system." He was also elected a member of the United States National Academy of Sciences and a fellow of the American Academy of Arts and Sciences, cementing his status as a leading figure in 20th-century biomedical science.

Personal life and legacy

Furchgott was known as a humble, dedicated, and intellectually rigorous scientist who inspired generations of students and colleagues. He was married twice and had three daughters. After his official retirement, he remained active in research, accepting a position as a distinguished professor at the University of Miami School of Medicine before later moving to Seattle. His discovery of EDRF/nitric oxide revolutionized pharmacology and medicine, directly leading to the development of revolutionary drugs like sildenafil (Viagra) and informing new treatments for angina pectoris, pulmonary hypertension, and septic shock. Robert F. Furchgott passed away in Seattle, Washington in 2009, leaving a legacy as the meticulous experimentalist who revealed the profound signaling role of a simple gas within the human body.

Category:American pharmacologists Category:Nobel laureates in Physiology or Medicine Category:1916 births Category:2009 deaths